The expression of SEMA3F was negatively correlated with overall survival in invasive BC patients with all breast cancer subtypes and in grade 1 (less aggressive) and grade 3 tumors (the most aggressive ones), denoting the importance of SEMA3F expression as a marker of poor survival (Fig. 1b). This evidence concerns the gene SEMA3F and breast carcinoma.